Impact of Pharmacological Management on Hospitalization Risk and Survival in Frontotemporal Dementia: A TriNetX‐based study
Individuals treated with benzodiazepines, typical antipsychotics, or Alzheimer's medications present a higher risk of hospitalization or critical care needs and poorer survival outcomes. Altogether, these findings suggest that these medications may be associated with adverse healthcare outcomes and reduced survival in this population. Better-informed prescribing practices could lead to more effective patient care, brain health equity, and improved outcomes in FTD treatment.
Authors
- Maria Rosa Alves da Silva (ORCID: https://orcid.org/0000-0001-9570-3996)
- Lorenza Pabst Botton
- Lucas Porcello Schilling (ORCID: https://orcid.org/0000-0002-9923-6982)
- Cristiano Schaffer Aguzzoli (ORCID: https://orcid.org/0000-0002-7378-3830)
- Fernando Jacob Lazzaretti
- Andressa de Oliveira Felício
- Julia Patatt
- BARBARA SUMAN BAHLIS
- Eduarda Faresin
- Fabricio Nery Garrafiel
Institutions
- Instituto do Cérebro (BR)
- Hospital São Lucas da PUCRS (BR)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70858_107388
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00